Form 4: Medpace Holdings Director Brian T. Carley Reports Stock Transactions
SEC Form 4
Director Brian T. Carley reported the vesting and conversion of restricted stock units into Medpace Holdings, Inc. common stock.
Summary
- On June 30, 2024, Brian T. Carley, a director of Medpace Holdings, Inc., reported a transaction involving restricted stock units.
- 78 restricted stock units vested and were converted into 78 shares of common stock.
- Following the transaction, Carley directly owns 156 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency to investors regarding the actions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| November 30, 2023 | Reporting Person was granted 313 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. |
| March 31, 2024 | First vesting date of restricted stock units. |
| June 30, 2024 | Transaction date: 78 restricted stock units vested and converted to common stock. |
| September 30, 2024 | Third vesting date of restricted stock units. |
| December 31, 2024 | Final vesting date of restricted stock units. |
| July 02, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.